Literature DB >> 8469634

Discordance between thallium-201 scintigraphy and coronary angiography in patients with Kawasaki disease: myocardial ischemia with normal coronary angiogram.

M Fukazawa1, J Fukushige, T Takeuchi, H Narabayashi, H Igarashi, T Hijii, K Ueda, Y Kuwabara, M Otsuka, Y Ichiya.   

Abstract

To assess the usefulness of radionuclide tests in detecting coronary occlusive lesions in children with Kawasaki disease, we compared the results of stress thallium-201 myocardial single photon emission computed tomography with dipyridamole infusion and coronary angiography in 34 patients (19 males and 15 females). Perfusion defects on the stress image only were categorized as transient and were attributed to coronary vascular disease in the presence of redistribution on the delayed image. Others were classified as persistent, due to myocardial damage. Five of the seven children (71%) with severe stenosis on coronary angiography showed persistent and/or transient perfusion defects. However, six of the 11 children (55%) with aneurysms but no obvious stenosis, and four of the 16 children (25%) with normal angiography, showed persistent and/or transient defects. After analyzing 20 individual segments of perfusion defects in the 15 children, six segments (30%) were attributed to the stenosis of supplying coronary arteries, six segments (30%) were related to the coronary aneurysms, and eight segments (40%) were unrelated to any abnormalities on angiography. Thus, significant discordance between the radionuclide and angiographic studies was demonstrated. These results suggest that coronary lesions, as conventionally defined by angiography and supplemented by echocardiography, may not completely identify all Kawasaki patients who may develop myocardial ischemia in the future or who had ischemia in the past.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8469634     DOI: 10.1007/BF00796982

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  35 in total

1.  EFFECT OF CORONARY VASODILATOR DRUGS ON RETROGRADE FLOW IN AREAS OF CHRONIC MYOCARDIAL ISCHEMIA.

Authors:  W M FAM; M MCGREGOR
Journal:  Circ Res       Date:  1964-10       Impact factor: 17.367

Review 2.  Pathological features of Kawasaki disease (mucocutaneous lymph node syndrome).

Authors:  B H Landing; E J Larson
Journal:  Am J Cardiovasc Pathol       Date:  1987

3.  Stress thallium-201 transaxial emission computed tomography: quantitative versus qualitative analysis for evaluation of coronary artery disease.

Authors:  N Tamaki; Y Yonekura; T Mukai; S Kodama; K Kadota; H Kambara; C Kawai; K Torizuka
Journal:  J Am Coll Cardiol       Date:  1984-12       Impact factor: 24.094

4.  Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilatation. III. Clinical trial.

Authors:  P C Albro; K L Gould; R J Westcott; G W Hamilton; J L Ritchie; D L Williams
Journal:  Am J Cardiol       Date:  1978-11       Impact factor: 2.778

5.  Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome.

Authors:  H Kato; S Koike; M Yamamoto; Y Ito; E Yano
Journal:  J Pediatr       Date:  1975-06       Impact factor: 4.406

6.  Clinicopathologic study of abnormal Q waves in Kawasaki disease (mucocutaneous lymph node syndrome). An infantile cardiac disease with myocarditis and myocardial infarction.

Authors:  H Fujiwara; C H Chen; T Fujiwara; K Nishioka; C Kawai; Y Hamashima
Journal:  Am J Cardiol       Date:  1980-04       Impact factor: 2.778

7.  Tomographic myocardial perfusion scintigraphy in children with Kawasaki disease.

Authors:  R P Spielmann; C A Nienaber; G Hausdorf; R Montz
Journal:  J Nucl Med       Date:  1987-12       Impact factor: 10.057

8.  Quantitative rotational thallium-201 tomography for identifying and localizing coronary artery disease.

Authors:  E E DePasquale; A C Nody; E G DePuey; E V Garcia; G Pilcher; C Bredlau; G Roubin; A Gober; A Gruentzig; P D'Amato
Journal:  Circulation       Date:  1988-02       Impact factor: 29.690

9.  Left ventricular dysfunction in patients with angina pectoris, normal epicardial coronary arteries, and abnormal vasodilator reserve.

Authors:  R O Cannon; R O Bonow; S L Bacharach; M V Green; D R Rosing; M B Leon; R M Watson; S E Epstein
Journal:  Circulation       Date:  1985-02       Impact factor: 29.690

10.  Cardiac biopsy of Kawasaki disease.

Authors:  C Yutani; S Go; T Kamiya; O Hirose; H Misawa; H Maeda; T Kozuka; S Onishi
Journal:  Arch Pathol Lab Med       Date:  1981-09       Impact factor: 5.534

View more
  5 in total

1.  Discordance between dipyridamole stress Tc-99m sestamibi SPECT and coronary angiography in patients with Kawasaki disease.

Authors:  Yun-Ching Fu; Chia-Hung Kao; Betau Hwang; Sheng-Ling Jan; Ching-Shiang Chi
Journal:  J Nucl Cardiol       Date:  2002 Jan-Feb       Impact factor: 5.952

2.  Ultrasound tissue characterization of the myocardium in patients after Kawasaki disease.

Authors:  Benedetta Leonardi; Vincenzo Giglio; Stephen P Sanders; Vincenzo Pasceri; Andrea De Zorzi
Journal:  Pediatr Cardiol       Date:  2010-08       Impact factor: 1.655

3.  Long-term outcome of coronary abnormalities in patients after Kawasaki disease.

Authors:  J Fukushige; N Takahashi; K Ueda; T Hijii; H Igarashi; A Ohshima
Journal:  Pediatr Cardiol       Date:  1996 Mar-Apr       Impact factor: 1.655

4.  Discordance between dipyridamole stress technetium-99m tetrofosmin single photon emission computed tomography and coronary angiography in patients with Kawasaki disease.

Authors:  Yun-Ching Fu; Yu-Chien Shiau; Shih-Chuan Tsai; Albert Kao; Betau Hwang; Ching-Shiang Chi
Journal:  Int J Cardiovasc Imaging       Date:  2002-10       Impact factor: 2.357

5.  Quantitative evaluation of myocardial fibrosis by cardiac integrated backscatter analysis in Kawasaki disease.

Authors:  Lijian Xie; Renjian Wang; Min Huang; Yongwei Zhang; Jie Shen; Tingting Xiao
Journal:  Cardiovasc Ultrasound       Date:  2016-01-12       Impact factor: 2.062

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.